< back to list

Videos

Share this video:

Post on twitter:

Driving drug development: Exploring the intersection of academe and industry

Length: 9 mins | Uploaded 2 days ago | 10 consolidated views

Related Videos

Driving drug development: Exploring the intersection of academe and industry
Length: 0:0 minutes.

International Symposium on Nitric Oxide – John Wallace
Length: 4:1 minutes.

International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters
Length: 0:0 minutes.

Lived it Lecture with David Young – Entrepreneurship 101 2010/11
Length: 57:27 minutes.

MaRS Future of Medicine™ Conference 2010 – Mark Lievonen, Sanofi Pasteur Ltd.
Length: 3:46 minutes.

Dx2010 Markers to Market: Patrice Sarrazin
Length: 2:56 minutes.

< back to list

Life science innovation: Out with the old, in with the new
What do the most successful companies such as Apple, Google and Toyota have in common? They innovate differently. Each has embraced a new innovation model: open innovation. Instead of relying solely

The future of medicine's so bright
Imagine a world where… drugs work reliably no one ever gets sick from their prescriptions harmful properties are designed out of all new drugs critically-ill patients entering the ICU expect a po

Why the US mid-term elections matter to the Canadian pharma industry
Take the Pill, originally uploaded by messyatwork The upcoming US Congress and Senate mid-term elections will have far-reaching, unforeseen consequences, whatever the result may be. The President a

New Models of Innovation in Life Sciences
As companies refocus on growth and innovation, it’s time to look at the approach to generating good ideas and turning them into products and services. For the majority of companies, this approac

Octane Medical Group: Building Ontario’s biotech community
In Kingston, Ontario, Tim Smith and Ian Grant have built an Ontario company with an impressive international presence. Since its founding in 2007, and with an internal team of just 15 people, MaRS cli

Rna Diagnostics appoints Dr. Harry Bear to Clinical Advisory Board
Toronto, March 28, 2012 – MaRS client Rna Diagnostics Inc., a molecular diagnostics company developing tools to assist in the management of cancer chemotherapy, today announces that it has appointed

Get More From MaRS		MaRS NEWSLETTERS
Facebook Twitter Vimeo Flickr	MaRS Charitable Registration Number 876682717 RR0001	Please enter your email address to subscribe to our newsletter

Website Sections

Videos

Driving drug development: Exploring the intersection of academe and industry

Related Videos

Related Articles & Workbooks

Related Blogs

Related News & Insights

Upcoming events